fda bpc 157 category 2 bulk drug substance list BPC-157 PASSED! Gabriel Alizaidy, MD, MS I also agree with you, the FDA's data pitch was very disappointing For the compounding industry, this is a positive vote. It does not immediately make… The peptide comeback narrative has

The peptide comeback narrative has a problem. FDA staff said no to all seven. Earlier this year, some peptides came off FDA's Category 2 list, the bucket for bulk drug substances FDA Survey: Half of Peptide Users Aren't Aware of FDA Approval Status FDA considers adding a dozen peptides to its bulk drug compounding list RAPS The FDA just dropped a 68 page PDF on if BPC 157 should be legal or not to compound. Their initial recommendation: DO NOT add BPC 157 to the 503A Bulks List. They're meeting this A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring!

SKU: 59585081655 · From vanierexcavation.com